EXOSC3 antibody (AA 81-130)

Catalog No. ABIN6736236

Product Details anti-EXOSC3 Antibody

Target: EXOSC3 (Exosome Component 3 (EXOSC3))

Binding Specificity: AA 81-130

Reactivity: Human, Mouse, Dog, Cow, Guinea Pig, Horse, Rabbit, Pig, Monkey, Chicken, Xenopus laevis

Host: Rabbit

Clonality: Polyclonal

Conjugate: This EXOSC3 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificity: Human EXOSC3

Predicted Reactivity: Percent identity by BLAST analysis: Human, Mouse, Dog, Horse, Pig, Guinea pig, Chicken, Xenopus (100%).

Purification: Immunoaffinity purified

Immunogen: Synthetic peptide located between aa81-130 of human EXOSC3 (Q9NQT5, NP_057126). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Elephant, Panda, Dog, Bovine, Rabbit, Horse, Pig, Opossum, Guinea pig, Turkey, Zebra finch, Chicken, Xenopus (100%), Platypus (92%).

Type of Immunogen: Synthetic peptide

Isotype: IgG

Application Details

Application Notes: Approved: IHC, IHC-P, WB (0.2 - 1 μg/mL)

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: After adding water, will consist of PBS buffer with 2 % sucrose

Concentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Handling Advice: Avoid repeat freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Target Details for EXOSC3

Target: EXOSC3 (Exosome Component 3 (EXOSC3))

Alternative Name: EXOSC3 / p10 (EXOSC3 Products)

Background: Name/Gene ID: EXOSC3

Synonyms: EXOSC3, BA3J10.7, p10, PCH1B, RP11-3J10.8, Rrp40p, CGI-102, Exosome component 3, HRrp-40, HRrp40p, RRP40

Gene ID: 51010

NCBI Accession: NP_057126

UniProt: Q9NQT5

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, SARS-CoV-2 Protein Interactome